Nasmed Ozel Saglik Hizmetleri Ticaret A.S.
BBIST:EGEPO4.38
TRY
-0.11
(-2.45%)
ISIN
TRENSMD00029
Return %
Stock
S&P 500
1Y
-43.12
14.20
3Y
-6.06
81.12
5Y
236.28
68.34
Capital Structure
TRY
•
in mil. unless spec.Working Capital
TRY
•
in mil. unless spec.Growth Rates
TRY
•
in mil. unless spec.Quarterly Revenue
TRY
•
in mil. unless spec.Quarterly Earnings Per Share
TRY
•
in mil. unless spec.Quarterly Dividends Per Share
TRY
•
in mil. unless spec.Company Description
- Full Time Employees
- 658
- Sector
- Health services
- Industry
- Hospital/Nursing management
- Address
- Izmir Turkey
- IPO Date
- Aug 23, 2021
- Website
- egepolhastanesi.com
- Similar Companies
- Business
- Nasmed Ozel Saglik Hizmetleri Ticaret A.S. is a Turkey-based healthcare services company that owns and operates private general and specialized hospitals under the Egepol Hospitals (Egepol Hastaneleri) brand. Founded in 2003 and headquartered in Izmir, Turkey, the company provides inpatient, outpatient, diagnostic, surgical, and emergency medical treatments across its hospital network, which comprises Egepol Hospital, Egepol Surgical Hospital, and Egepol International Hospital. Nasmed delivers systematic medical services across a broad spectrum of clinical specialties, including general surgery; cardiovascular surgery; brain and neurosurgery; orthopedics and traumatology; obstetrics and gynecology; pediatrics and pediatric subspecialties; internal medicine; cardiology; neurology; pulmonology; gastroenterology; dermatology; psychiatry; physical therapy and rehabilitation; ophthalmology; otorhinolaryngology; urology; and plastic, reconstructive, and aesthetic surgery. Its clinical infrastructure also provides specialized critical care through adult, neonatal, and cardiovascular intensive care units; 24/7 emergency medical response; comprehensive diagnostic imaging and radiology services, including magnetic resonance imaging, computed tomography, ultrasonography, and digital radiography; accredited clinical laboratory and pathology testing; oral and dental health treatments; nutritional counseling; and comprehensive preventative check-up packages. Serving local, regional, and international patient bases, the company caters to private health insurance policyholders, corporate partners, social security beneficiaries, and global medical tourists. In recent strategic developments, Nasmed completed the multi-phase technological renovation and facility modernization of its hospital complex, bringing its operational infrastructure to full capacity at 325 licensed hospital beds. To strengthen its financial position and support corporate growth, the company completed a significant bonus share capital increase, raising its paid-in capital from TRY 125 million to TRY 500 million through internal inflation adjustment reserves. In addition, Nasmed has accelerated its international healthcare tourism expansion by deploying targeted marketing programs and multilingual patient coordination networks across Europe and the Middle East, with a specific operational focus on obesity surgery, aesthetic procedures, dental care, and advanced orthopedic interventions.